Jonathan Kurtz

Jonathan Kurtz is an experienced immunologist currently serving as Associate Director of Translational Immunology at Century Therapeutics, Inc., following the acquisition of Clade Therapeutics in April 2024, where Jonathan held a similar title. Prior roles include Principal Scientist and Senior Scientist positions at Flagship Pioneering, where Jonathan contributed to Flagship Labs 72, Inc. Additionally, Jonathan served as Immunology Lead for both Laulima Government Solutions, LLC, and the National Institute of Allergy and Infectious Diseases, focusing on high-consequence viruses. Jonathan's academic background includes a Ph.D. in Biomedical Sciences from Tulane University School of Medicine and a Bachelor of Science in Biological Sciences from Loyola University New Orleans.